CALABRESE, Cecilia
 Distribuzione geografica
Continente #
EU - Europa 2.117
NA - Nord America 2.046
AS - Asia 474
SA - Sud America 23
AF - Africa 13
Continente sconosciuto - Info sul continente non disponibili 2
OC - Oceania 1
Totale 4.676
Nazione #
US - Stati Uniti d'America 2.039
IE - Irlanda 737
IT - Italia 356
UA - Ucraina 292
GB - Regno Unito 236
DE - Germania 219
CN - Cina 172
SG - Singapore 149
SE - Svezia 84
FI - Finlandia 81
KR - Corea 74
GR - Grecia 54
TR - Turchia 54
FR - Francia 26
BE - Belgio 17
BR - Brasile 15
SC - Seychelles 12
IN - India 10
CO - Colombia 7
CA - Canada 6
NL - Olanda 4
HK - Hong Kong 3
ID - Indonesia 3
JP - Giappone 3
AT - Austria 2
CZ - Repubblica Ceca 2
EU - Europa 2
RO - Romania 2
VN - Vietnam 2
AU - Australia 1
CH - Svizzera 1
IR - Iran 1
LB - Libano 1
MX - Messico 1
NO - Norvegia 1
PE - Perù 1
PH - Filippine 1
PL - Polonia 1
PT - Portogallo 1
RU - Federazione Russa 1
TW - Taiwan 1
ZA - Sudafrica 1
Totale 4.676
Città #
Dublin 737
Jacksonville 456
Chandler 318
Santa Clara 124
Princeton 111
Bremen 110
Roxbury 98
Ann Arbor 90
Seoul 68
Singapore 67
Medford 62
Cambridge 61
Wilmington 59
Boardman 41
Houston 41
Mountain View 32
Woodbridge 30
Beijing 29
Ashburn 25
Munich 24
Bari 23
Caserta 23
San Mateo 23
Jinan 21
Naples 18
New York 18
Brussels 17
Des Moines 17
Rome 17
Marano Di Napoli 13
Shenyang 13
Fuzhou 12
Nanchang 9
Nanjing 9
Napoli 9
Guangzhou 8
Helsinki 8
Tianjin 8
Düsseldorf 7
Ningbo 7
Putian 7
Cursi 6
Istanbul 6
Los Angeles 6
Nuremberg 6
Villaricca 6
Changsha 5
Fisciano 5
Hangzhou 5
Milan 5
Norwalk 5
Redwood City 5
Casavatore 4
Lappeenranta 4
Palermo 4
Pozzuoli 4
Putignano 4
Santeramo in Colle 4
Taiyuan 4
Zhengzhou 4
Borås 3
Boydton 3
Hong Kong 3
Jakarta 3
Lanzhou 3
Mumbai 3
Pescara 3
Seattle 3
Sommatino 3
Taizhou 3
Venice 3
Alessandria 2
Arad 2
Auburn Hills 2
Avellino 2
Aversa 2
Bologna 2
Brescia 2
Brno 2
Chungcheongnam-do 2
Como 2
Crotone 2
Dearborn 2
Dong Ket 2
Elora 2
Ercolano 2
Fairfield 2
Falls Church 2
Foz Do Iguaçu 2
Frankfurt am Main 2
Haikou 2
Hebei 2
Hefei 2
Kunming 2
Limatola 2
Mangalore 2
Montreal 2
Monza 2
Noicattaro 2
Nola 2
Totale 3.053
Nome #
Tollerabilità del GSH inalatorio in pazienti pediatrici e adulti con fibrosi cistica 127
A CASE OF A PULMONARY EPITHELIOID HEMANGIOENDOTHELIOMA TRANSFORMED INTO AN EPITHELIOID ANGIOSARCOMA 81
Impact of long-term treatment with inhaled corticosteroids and bronchodilators on lung function in a patient with post-infectious bronchiolitis obliterans 81
Evidence of angiogenesis in bronchial biopsies of smokers with and without airway obstruction 77
Secretory phospholipases A2 induce beta-glucuronidase release and IL-6 production from human lung macrophages 77
Ruolo dei fattori di crescita nella induzione della proliferazione fibroblastica nella patogenesi della fibrosi polmonare idiopatica 75
Exposure to Submicron Particles (PM1.0) from Diesel Exhaust and Pollen Allergens of Human Lung Epithelial Cells Induces Morphological Changes of Mitochondria Tonifilaments and Rough Endoplasmic Reticulum 71
Immunoflogosi nell’Asma Bronchiale 69
H-Prune through GSK-3β interaction sustains canonical WNT/β-catenin signaling enhancing cancer progression in NSCLC. 67
Lung mast cells are a source of secreted phospholipases A(2). 65
Asma Bronchiale (recenti acquisizioni sperimentali e contributi personali) 64
Arachidonic acid metabolism in inflammatory cells of patients with bronchial asthma 61
[Clinical use of recombinant IFN alfa-2b in the treatment of primary cancer of the lung (preliminary results)] 61
L'ASMA GRAVE: FENOTIPI CLINICI 60
ANGIOGENETIC AND APOPTOTIC PROCESS IN THE AIRWAYS OF SYMPTOMATIC SMOKERS WITH AND WITHOUT A CONTRALATERAL NON SMALL CELL LUNG CANCER 60
Application of proteomics and peptidomics to COPD. 59
VASCULAR REMODELLING IN BRONCHIAL MUCOSA OF SMOKERS WITH AND WITHOUT AIRWAY OBSTRUCTION 59
CARATTERISTICHE CLINICHE E MONITORAGGIO DEI PAZIENTI AFFETTI DA ASMA BRONCHIALE GRAVE DI DIFFICILE CONTROLLO 58
Imbalance of circulating dendritic cell subsets in chronic obstructive pulmonary disease. 57
Omalizumab, the first available antibody for biological treatment of severe asthma: more than a decade of real-life effectiveness 57
T cell activation state in the induced sputum of asthmatics treated with budesonide 57
ANGIOGENESIS IN BRONCHIAL BIOPSIES OF SYMPTOMATIC SMOKERS WITH AND WITHOUT LUNG CANCER 57
CORRELAZIONI TRA CELLULARITA' E MEDIATORI CHIMICI NEL LIQUIDO DI LAVAGGIO BRONCOALVEOLARE IN PAZIENTI CON ASMA BRONCHIALE ATOPICO 56
BRONCHIAL VASCULARITY IN THE AIRWAYS OF CHRONIC BRONCHITIS AND COPD SMOKERS 56
Dupilumab: A novel treatment for asthma 56
A CASE OF DOUBLE AORTIC ARCH SUGGESTED BY THE ANALYSIS OF THE FLOW-VOLUME CURVE 55
Abdominal adiposity is an early marker of pulmonary function impairment: Findings from a Mediterranean Italian female cohort 55
Obstructive sleep apnea and cardiovascular risks in the elderly population 55
Basophil activation test for staphylococcus enterotoxins in severe asthmatic patients 55
MONITORAGGIO CLINICO E IMMUNOLOGICO DI UN GRUPPO DI PAZIENTI AFFETTI DA ASMA BRONCHIALE ATOPICO O ASMA BRONCHIALE E RINITE ALLERGICA IN TRATTAMENTO IPOSENSIBILIZZANTE SPECIFICO PER VIA SOTTOCUTANEA OD ORALE 53
New perspectives in asthma treatment 51
Cellular mechanisms underlying eosinophilic and neutrophilic airway inflammation in asthma 51
ANTAGONISTI DEI LEUCOTRIENI E DI ALTRI MEDIATORI LIPIDICI 50
Correlation study of semi-quantitative CT emphysema score with the BODE index in COPD patients 50
Validation of Murray sputum purulence scale in the Italian Registry of Bronchiectasis (IRIDE) 50
Dysregulation of lipid metabolism and pathological inflammation in patients with COVID-19 50
FARMACI ATTIVI SUI MECCANISMI DELLA FLOGOSI 49
Asma e gravidanza 48
NMR metabolomic analysis of exhaled breath condensate of asthmatic patients at two different temperatures 48
NMR spectroscopy metabolomic profiling of exhaled breath condensate in patients with stable and unstable cystic fibrosis 47
Role of monocyte/macrophage population in immune response 47
INFLUENZA DELL'INQUINAMENTO AMBIENTALE SULLA FUNZIONE RESPIRATORIA 47
IFNY TRIGGERS APOPTOSIS IN VITRO M.T. ACTIVATED ALVEOLAR MACROPHAGES 47
AGONISTI BETA2-ADRENERGICI 47
Inhibition of Cytosolic Phospholipase A2 in Human Neutrophils by Oxatomide 46
Risultati preliminari sull'impiego della picotamide monoidrata in pazienti asmatici 46
Inhaled glutathione tolerability and efficacy in patients with cystic fibrosis 45
Clinical impact of nasal budesonide treatment on COPD patients with coexistent rhinitis 45
CYTOFLUORIMETRIC ANALYSIS OF CYTOKINE-PRODUCING LYMPHOCYTES IN BAL FROM TB PATIENTS 44
IFNg triggers apoptosis in vitro M.T. activated alveolar macrophages 44
Upregulation of miR-21 by Ras in vivo and its role in tumor growth 43
IL POLMONE NELL'ARTRITE REUMATOIDE E NEL LUPUS ERITEMATOSO SISTEMICO 43
Effetti della stimolazione nasale con estratto di parietaria sui livelli di no esalato in pazienti con rinite allergica intermittente 43
Role of FDG-PET scan in staging of pulmonary epithelioid hemangioendothelioma 43
EVALUATION OF THE EFFICIENCY OF CORTICOSTEROID (BECLOMETIIASONE-DIPROPRIONATE) USE IN ATOPIC PATIENTS WITH MILD ASTHMA 42
Pharmacologic rationale underlying the therapeutic effects of tiotropium/olodaterol in COPD 42
A storm of stones in the lungs: an uncommon sequela of varicella pneumonia 42
ASMA E MENOPAUSA 41
Asymmetric dimethylarginine (ADMA): will be or will not be a new revolutionary biomarker of bronchial asthma 41
Randomized, single blind, controlled trial of inhaled glutathione vs placebo in patients with cystic fibrosis 41
FIBROBLAST PROLIFERATION INDUCED BY GROWTH FACTORS IN DIOPATHIC PULMONARY FIBROSIS 40
NEUROPEPTIDE EXPRESSION IN THE AIRWAYS OF COPD PATIENTS AND SMOKERS WITH NORMAL LUNG FUNCTION. 39
PHENOTYPIC FEATURES AND ACTIVATION OF ALVEOLAR MACROPHAGES IN ATOPIC ASTHMATIC PATIENTS 39
Somatostatin-Dependent Regulation of Alveolar Macrophages Activation and Cytokine Production 39
The serum metabolome of moderate and severe covid-19 patients reflects possible liver alterations involving carbon and nitrogen metabolism 39
Association between exhaled nitric oxide and nasal polyposis in severe asthma 38
SCHEMI DI TERAPIA DELL'ASMA BRONCHIALE 37
Vascular remodelling in COPD airways 37
Evaluation of Allergic Diseases, Symptom Control, and Relation to Infections in a Group of Italian Elite Mountain Bikers. 35
Lipid mediators from mast cells and basophils in allergic diseases 35
FARMACI ANTIMUSCARINICI 35
Intranasal budesonide improves quality of life in patient with COPD and chronic nasal symptoms 35
Association between Renal Function at Admission and COVID-19 in-Hospital Mortality in Southern Italy: Findings from the Prospective Multicenter Italian COVOCA Study 34
S. aureus and IgE-mediated diseases: pilot or copilot? A narrative review 34
Inibitori delle molecole di adesione 34
Omalizumab lowers asthma exacerbations, oral corticosteroid intake and blood eosinophils: Results of a 5-YEAR single-centre observational study 34
Benralizumab: From the Basic Mechanism of Action to the Potential Use in the Biological Therapy of Severe Eosinophilic Asthma 33
Tiotropium Respimat Inhaler and the Risk of Death in COPD 33
METABOLISM OF LIPID MEDIATORS IN HUMAN EOSINOPHILS 33
Inibitori dei Fattori di crescita 33
TOSSE CRONICA E MALATTIA DA REFLUSSO GASTROESOFAGEO 33
CONFRONTO DEI FENOMENI DI ANGIOGENESI E DI PROLIFERAZIONE CELLULARE NELLE VIE AEREE DI FUMATORI SINTOMATICI CON E SENZA BPCO 33
Three Month Follow-Up of Patients With COVID-19 Pneumonia Complicated by Pulmonary Embolism 32
Recurrent respiratory infections caused by a double aortic arch: The diagnostic role of spirometry 32
Basophil activation test for Staphylococcus aureus enterotoxins in severe asthmatic patients 32
Diagnostica allergologica "in vivo" 31
EXPLORING THE ROLE OF KREBS VON DEN LUNGEN-6 (KL-6) IN SEVERE TO CRITICAL COVID-19: A SINGLE INSTITUTION EXPERIENCE 30
IMMUNOLOGICAL INTERACTIONS BETWEEN HUMAN EOSINOPHILS AND CARDIAC MAST CELLS 30
Asthma control in severe asthmatics under treatment with omalizumab: A cross-sectional observational study in Italy 28
ACE Gene I/D Polymorphism and Acute Pulmonary Embolism in COVID19 Pneumonia: A Potential Predisposing Role 28
Economic impact of mepolizumab in uncontrolled severe eosinophilic asthma, in real life 28
Switching from omalizumab to mepolizumab: real-life experience from Southern Italy. 27
Incidental late diagnosis of cystic fibrosis following AH1N1 influenza virus pneumonia: A case report 27
Novel Biological Therapies for Severe Asthma Endotypes 26
Evolution of the Clinical Profile and Outcomes of Unvaccinated Patients Affected by Critical COVID-19 Pneumonia from the Pre-Vaccination to the Post-Vaccination Waves in Italy. 26
Impact of liver fibrosis on COVID-19 in-hospital mortality in Southern Italy 25
Endoscopic central airway recanalization to enable first line pembrolizumab treatment in a PD-L1 strongly positive non-small cell lung cancer: a case report 25
Staphylococcus Aureus in chronic airway diseases: An overview 25
Characteristics and treatment regimens across ERS SHARP severe asthma registries 25
Chronic rhinosinusitis with nasal polyps impact in severe asthma patients: Evidences from the Severe Asthma Network Italy (SANI) registry 25
Totale 4.598
Categoria #
all - tutte 24.022
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 24.022


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020297 0 0 0 0 76 23 102 16 31 10 28 11
2020/2021758 58 2 81 53 166 16 103 76 7 106 73 17
2021/2022779 27 1 0 5 213 48 16 32 26 119 54 238
2022/20231.436 137 9 28 108 217 113 24 59 686 14 17 24
2023/2024536 49 21 25 42 187 24 26 9 6 4 51 92
2024/2025328 6 80 19 50 173 0 0 0 0 0 0 0
Totale 4.943